Cargando…
Rational design of cancer gene panels with OncoPaD
BACKGROUND: Profiling the somatic mutations of genes which may inform about tumor evolution, prognostics and treatment is becoming a standard tool in clinical oncology. Commercially available cancer gene panels rely on manually gathered cancer-related genes, in a “one-size-fits-many” solution. The d...
Autores principales: | Rubio-Perez, Carlota, Deu-Pons, Jordi, Tamborero, David, Lopez-Bigas, Nuria, Gonzalez-Perez, Abel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5047348/ https://www.ncbi.nlm.nih.gov/pubmed/27716338 http://dx.doi.org/10.1186/s13073-016-0349-1 |
Ejemplares similares
-
Improving the prediction of the functional impact of cancer mutations by baseline tolerance transformation
por: Gonzalez-Perez, Abel, et al.
Publicado: (2012) -
OncodriveROLE classifies cancer driver genes in loss of function and activating mode of action
por: Schroeder, Michael P., et al.
Publicado: (2014) -
IntOGen-mutations identifies cancer drivers across tumor types
por: Gonzalez-Perez, Abel, et al.
Publicado: (2013) -
Cancer Genome Interpreter annotates the biological and clinical relevance of tumor alterations
por: Tamborero, David, et al.
Publicado: (2018) -
OncodriveFML: a general framework to identify coding and non-coding regions with cancer driver mutations
por: Mularoni, Loris, et al.
Publicado: (2016)